Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05501730 · ClinicalTrials.gov registry record
Use of the Quantra QPlus Sytem in Cardiac Surgery
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 128
- Enrollment target
NCT05501730 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 128 participants.
The verdict
NCT05501730 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 128 participants
- Enrollment target
Study Summary
Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
Interventions
- DIAGNOSTIC_TEST Quantra QPlus System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2021-06-15 |
| Est. Completion | 2021-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05501730
The ClinicalTrials.gov registry entry for NCT05501730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantra QPlus System is the first listed.
NCT05501730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05501730 about?
NCT05501730 is a clinical study titled "Use of the Quantra QPlus Sytem in Cardiac Surgery". Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
What is the current status of trial NCT05501730?
This trial is currently completed. The enrollment target is 128 participants. The study started on 2021-06-15. Estimated completion is 2021-12-15.
What interventions are being tested in trial NCT05501730?
The interventions under investigation include: Quantra QPlus System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05501730?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.